Thermo Fisher Scientific Inc (TMO) Holdings Boosted by 361 Capital LLC

361 Capital LLC grew its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 8.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,121 shares of the medical research company’s stock after purchasing an additional 1,093 shares during the quarter. 361 Capital LLC’s holdings in Thermo Fisher Scientific were worth $2,672,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Cambridge Investment Research Advisors Inc. raised its position in shares of Thermo Fisher Scientific by 4.3% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 10,670 shares of the medical research company’s stock worth $1,639,000 after acquiring an additional 437 shares during the last quarter. Bluestein R H & Co. raised its position in shares of Thermo Fisher Scientific by 75.2% during the first quarter. Bluestein R H & Co. now owns 3,902 shares of the medical research company’s stock worth $599,000 after acquiring an additional 1,675 shares during the last quarter. Azimuth Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 0.8% during the first quarter. Azimuth Capital Management LLC now owns 3,210 shares of the medical research company’s stock worth $493,000 after acquiring an additional 25 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 7.0% during the first quarter. Geode Capital Management LLC now owns 3,562,443 shares of the medical research company’s stock worth $546,354,000 after acquiring an additional 232,624 shares during the last quarter. Finally, Winslow Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 25.0% during the first quarter. Winslow Capital Management LLC now owns 2,198,174 shares of the medical research company’s stock worth $337,639,000 after acquiring an additional 439,847 shares during the last quarter. 86.16% of the stock is currently owned by institutional investors.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at $47,582,981.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.49% of the stock is owned by corporate insiders.

A number of equities research analysts have recently weighed in on TMO shares. Cowen restated a “buy” rating and set a $200.00 target price on shares of Thermo Fisher Scientific in a research report on Friday, September 1st. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Tuesday, August 22nd. They noted that the move was a valuation call. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research report on Thursday, September 7th. Goldman Sachs Group started coverage on Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price for the company. Finally, Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Thursday, October 26th. One research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and an average price target of $205.21.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up $1.42 during trading on Thursday, hitting $183.87. The company’s stock had a trading volume of 2,262,900 shares, compared to its average volume of 1,561,349. Thermo Fisher Scientific Inc has a 12 month low of $139.88 and a 12 month high of $201.20. The company has a market capitalization of $73,161.61, a P/E ratio of 20.05, a P/E/G ratio of 1.67 and a beta of 1.06. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the company earned $2.03 earnings per share. The company’s revenue for the quarter was up 13.9% compared to the same quarter last year. equities research analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.33%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.19%.

ILLEGAL ACTIVITY NOTICE: “Thermo Fisher Scientific Inc (TMO) Holdings Boosted by 361 Capital LLC” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2017/12/07/thermo-fisher-scientific-inc-tmo-holdings-boosted-by-361-capital-llc.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit